VIATRIS INC (VTRS) Stock Fundamental Analysis
USA - NASDAQ:VTRS - US92556V1061 - Common Stock
10.12 USD
+0.01 (+0.1%)
10.25 USD
+0.13 (+1.28%)
Overall VTRS gets a fundamental rating of 4 out of 10. We evaluated VTRS against 192 industry peers in the Pharmaceuticals industry. VTRS has a medium profitability rating, but doesn't score so well on its financial health evaluation. VTRS is valued quite cheap, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
VTRS had positive earnings in the past year.
In the past year VTRS had a positive cash flow from operations.
In multiple years VTRS reported negative net income over the last 5 years.
Each year in the past 5 years VTRS had a positive operating cash flow.
1.2 Ratios
The Return On Assets of VTRS (-9.03%) is better than 67.19% of its industry peers.
With a decent Return On Equity value of -22.27%, VTRS is doing good in the industry, outperforming 65.63% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 3.61%, VTRS belongs to the top of the industry, outperforming 80.73% of the companies in the same industry.
VTRS had an Average Return On Invested Capital over the past 3 years of 4.05%. This is significantly below the industry average of 15.37%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -9.03% | ||
| ROE | -22.27% | ||
| ROIC | 3.61% |
ROA(3y)0.91%
ROA(5y)-0.13%
ROE(3y)2.24%
ROE(5y)-0.48%
ROIC(3y)4.05%
ROIC(5y)3.56%
1.3 Margins
VTRS has a better Operating Margin (10.13%) than 82.81% of its industry peers.
In the last couple of years the Operating Margin of VTRS has declined.
Looking at the Gross Margin, with a value of 40.15%, VTRS is in the better half of the industry, outperforming 61.98% of the companies in the same industry.
VTRS's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.13% | ||
| PM (TTM) | N/A | ||
| GM | 40.15% |
OM growth 3Y2.29%
OM growth 5Y-3.04%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.33%
GM growth 5Y1.02%
2. Health
2.1 Basic Checks
VTRS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
VTRS has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, VTRS has more shares outstanding
The debt/assets ratio for VTRS has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 0.89, we must say that VTRS is in the distress zone and has some risk of bankruptcy.
VTRS has a Altman-Z score (0.89) which is in line with its industry peers.
VTRS has a debt to FCF ratio of 7.49. This is a slightly negative value and a sign of low solvency as VTRS would need 7.49 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 7.49, VTRS is doing good in the industry, outperforming 79.17% of the companies in the same industry.
A Debt/Equity ratio of 0.82 indicates that VTRS is somewhat dependend on debt financing.
The Debt to Equity ratio of VTRS (0.82) is worse than 71.35% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | 7.49 | ||
| Altman-Z | 0.89 |
ROIC/WACC0.49
WACC7.42%
2.3 Liquidity
A Current Ratio of 1.37 indicates that VTRS should not have too much problems paying its short term obligations.
The Current ratio of VTRS (1.37) is worse than 72.40% of its industry peers.
A Quick Ratio of 0.77 indicates that VTRS may have some problems paying its short term obligations.
With a Quick ratio value of 0.77, VTRS is not doing good in the industry: 82.81% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.37 | ||
| Quick Ratio | 0.77 |
3. Growth
3.1 Past
The earnings per share for VTRS have decreased strongly by -14.65% in the last year.
Measured over the past years, VTRS shows a decrease in Earnings Per Share. The EPS has been decreasing by -9.73% on average per year.
Looking at the last year, VTRS shows a decrease in Revenue. The Revenue has decreased by -4.46% in the last year.
Measured over the past years, VTRS shows a small growth in Revenue. The Revenue has been growing by 5.09% on average per year.
EPS 1Y (TTM)-14.65%
EPS 3Y-10.45%
EPS 5Y-9.73%
EPS Q2Q%-10.67%
Revenue 1Y (TTM)-4.46%
Revenue growth 3Y-6.25%
Revenue growth 5Y5.09%
Sales Q2Q%0.23%
3.2 Future
Based on estimates for the next years, VTRS will show a small growth in Earnings Per Share. The EPS will grow by 2.64% on average per year.
VTRS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.14% yearly.
EPS Next Y-12.01%
EPS Next 2Y-3.03%
EPS Next 3Y0.91%
EPS Next 5Y2.64%
Revenue Next Year-6.08%
Revenue Next 2Y-2.31%
Revenue Next 3Y-1.04%
Revenue Next 5Y0.14%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 4.34 indicates a rather cheap valuation of VTRS.
Based on the Price/Earnings ratio, VTRS is valued cheaply inside the industry as 96.88% of the companies are valued more expensively.
VTRS is valuated cheaply when we compare the Price/Earnings ratio to 25.83, which is the current average of the S&P500 Index.
VTRS is valuated cheaply with a Price/Forward Earnings ratio of 4.06.
VTRS's Price/Forward Earnings ratio is rather cheap when compared to the industry. VTRS is cheaper than 97.92% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 32.68. VTRS is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 4.34 | ||
| Fwd PE | 4.06 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, VTRS is valued cheaply inside the industry as 97.40% of the companies are valued more expensively.
92.71% of the companies in the same industry are more expensive than VTRS, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.91 | ||
| EV/EBITDA | 5.68 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.03%
EPS Next 3Y0.91%
5. Dividend
5.1 Amount
VTRS has a Yearly Dividend Yield of 4.58%, which is a nice return.
VTRS's Dividend Yield is rather good when compared to the industry average which is at 6.87. VTRS pays more dividend than 96.88% of the companies in the same industry.
VTRS's Dividend Yield is rather good when compared to the S&P500 average which is at 2.39.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.58% |
5.2 History
VTRS has been paying a dividend for at least 10 years, so it has a reliable track record.
VTRS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
5.3 Sustainability
VTRS has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-16.42%
EPS Next 2Y-3.03%
EPS Next 3Y0.91%
10.12
+0.01 (+0.1%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners85.59%
Inst Owner ChangeN/A
Ins Owners0.25%
Ins Owner Change1.07%
Market Cap11.80B
Revenue(TTM)14.74B
Net Income(TTM)-3.47B
Analysts71.25
Price Target11.98 (18.38%)
Short Float %2.48%
Short Ratio3.27
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.58% |
Yearly Dividend0.48
Dividend Growth(5Y)N/A
DP-16.42%
Div Incr Years0
Div Non Decr Years3
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.75%
Min EPS beat(2)0.14%
Max EPS beat(2)9.36%
EPS beat(4)3
Avg EPS beat(4)2.74%
Min EPS beat(4)-7.28%
Max EPS beat(4)9.36%
EPS beat(8)4
Avg EPS beat(8)0.86%
EPS beat(12)7
Avg EPS beat(12)1.16%
EPS beat(16)10
Avg EPS beat(16)2.05%
Revenue beat(2)1
Avg Revenue beat(2)-0.04%
Min Revenue beat(2)-1.38%
Max Revenue beat(2)1.3%
Revenue beat(4)1
Avg Revenue beat(4)-1.31%
Min Revenue beat(4)-4.31%
Max Revenue beat(4)1.3%
Revenue beat(8)1
Avg Revenue beat(8)-1.98%
Revenue beat(12)1
Avg Revenue beat(12)-2.35%
Revenue beat(16)2
Avg Revenue beat(16)-2.22%
PT rev (1m)6.43%
PT rev (3m)9.93%
EPS NQ rev (1m)-0.02%
EPS NQ rev (3m)1.25%
EPS NY rev (1m)0.22%
EPS NY rev (3m)3.33%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)-0.49%
Revenue NY rev (1m)0.19%
Revenue NY rev (3m)0.92%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 4.34 | ||
| Fwd PE | 4.06 | ||
| P/S | 0.84 | ||
| P/FCF | 6.91 | ||
| P/OCF | 5.72 | ||
| P/B | 0.76 | ||
| P/tB | N/A | ||
| EV/EBITDA | 5.68 |
EPS(TTM)2.33
EY23.02%
EPS(NY)2.49
Fwd EY24.62%
FCF(TTM)1.46
FCFY14.47%
OCF(TTM)1.77
OCFY17.5%
SpS12.11
BVpS13.36
TBVpS-6.43
PEG (NY)N/A
PEG (5Y)N/A
Graham Number26.46
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -9.03% | ||
| ROE | -22.27% | ||
| ROCE | 4.57% | ||
| ROIC | 3.61% | ||
| ROICexc | 3.69% | ||
| ROICexgc | 14.98% | ||
| OM | 10.13% | ||
| PM (TTM) | N/A | ||
| GM | 40.15% | ||
| FCFM | 12.1% |
ROA(3y)0.91%
ROA(5y)-0.13%
ROE(3y)2.24%
ROE(5y)-0.48%
ROIC(3y)4.05%
ROIC(5y)3.56%
ROICexc(3y)4.16%
ROICexc(5y)3.64%
ROICexgc(3y)17.86%
ROICexgc(5y)17.54%
ROCE(3y)5.12%
ROCE(5y)4.54%
ROICexgc growth 3Y-9.04%
ROICexgc growth 5Y-13.17%
ROICexc growth 3Y4.9%
ROICexc growth 5Y-4.57%
OM growth 3Y2.29%
OM growth 5Y-3.04%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.33%
GM growth 5Y1.02%
F-Score4
Asset Turnover0.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | 7.49 | ||
| Debt/EBITDA | 3.05 | ||
| Cap/Depr | 12.94% | ||
| Cap/Sales | 2.53% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 49.28% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.37 | ||
| Quick Ratio | 0.77 | ||
| Altman-Z | 0.89 |
F-Score4
WACC7.42%
ROIC/WACC0.49
Cap/Depr(3y)14.64%
Cap/Depr(5y)17.2%
Cap/Sales(3y)2.72%
Cap/Sales(5y)3.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14.65%
EPS 3Y-10.45%
EPS 5Y-9.73%
EPS Q2Q%-10.67%
EPS Next Y-12.01%
EPS Next 2Y-3.03%
EPS Next 3Y0.91%
EPS Next 5Y2.64%
Revenue 1Y (TTM)-4.46%
Revenue growth 3Y-6.25%
Revenue growth 5Y5.09%
Sales Q2Q%0.23%
Revenue Next Year-6.08%
Revenue Next 2Y-2.31%
Revenue Next 3Y-1.04%
Revenue Next 5Y0.14%
EBIT growth 1Y1.9%
EBIT growth 3Y-4.1%
EBIT growth 5Y1.89%
EBIT Next Year-5.71%
EBIT Next 3Y0.26%
EBIT Next 5Y0.47%
FCF growth 1Y-16.49%
FCF growth 3Y-7.94%
FCF growth 5Y6.95%
OCF growth 1Y-17.35%
OCF growth 3Y-8.61%
OCF growth 5Y5.01%
VIATRIS INC / VTRS FAQ
What is the ChartMill fundamental rating of VIATRIS INC (VTRS) stock?
ChartMill assigns a fundamental rating of 4 / 10 to VTRS.
Can you provide the valuation status for VIATRIS INC?
ChartMill assigns a valuation rating of 7 / 10 to VIATRIS INC (VTRS). This can be considered as Undervalued.
What is the profitability of VTRS stock?
VIATRIS INC (VTRS) has a profitability rating of 5 / 10.
Can you provide the financial health for VTRS stock?
The financial health rating of VIATRIS INC (VTRS) is 3 / 10.
Can you provide the expected EPS growth for VTRS stock?
The Earnings per Share (EPS) of VIATRIS INC (VTRS) is expected to decline by -12.01% in the next year.